[Pharmacoeconomy in acne--evaluation of benefit and economics].
Standard
[Pharmacoeconomy in acne--evaluation of benefit and economics]. / Radtke, Marc; Schäfer, Ines; Augustin, Matthias.
In: J DTSCH DERMATOL GES, Vol. 8, No. 1, 1, 2010, p. 105-114.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Pharmacoeconomy in acne--evaluation of benefit and economics].
AU - Radtke, Marc
AU - Schäfer, Ines
AU - Augustin, Matthias
PY - 2010
Y1 - 2010
N2 - Acne belongs to the most common skin diseases and has a prevalence in the adolescence of nearly 100% and in adults of about 4%. The quality of life indes is significantly reduced und has impact on daily activities and social life and physical and psychological well being as well. The socioeconomic relevance is based not only on its prevalence but on direct and indirect costs. For acne therapy the knowledge on therapeutic costs is of importance but the cost benefit ratio as well.
AB - Acne belongs to the most common skin diseases and has a prevalence in the adolescence of nearly 100% and in adults of about 4%. The quality of life indes is significantly reduced und has impact on daily activities and social life and physical and psychological well being as well. The socioeconomic relevance is based not only on its prevalence but on direct and indirect costs. For acne therapy the knowledge on therapeutic costs is of importance but the cost benefit ratio as well.
M3 - SCORING: Zeitschriftenaufsatz
VL - 8
SP - 105
EP - 114
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
IS - 1
M1 - 1
ER -